Abstract: The present disclosure describes a nanoparticle comprising a three dimensional DNA nanocage and a payload biological macromolecule, and methods of assembly thereof.

Abstract: The disclosure relates to a new Alamouti-based mapping scheme for use in a real field FBMC modulation system which can reduce FBMC-intrinsic interference and allows approaching optimal performance. The Alamouti-based mapping scheme proposed herein can be used for implementing space-time or space-frequency block codes (STBC/SFBC) codes. The proposed Alamouti-based mapping scheme suggests specific patterns to negate/invert signs of the modulation symbols of Alamouti pairs in the Alamouti mapping. By using these special patterns of sign negation, the FBMC-intrinsic interference can be reduced significantly so that it may become possible to use conventional Alamouti demapping/decoding procedures on the receiving side with an overall acceptable performance in real life systems.

Abstract: A filterbank-based multicarrier transmitter for transmitting a multicarrier signal is disclosed, the multicarrier signal comprising a synchronization part and a payload part, the synchronization part comprising K1 frequency sub-channels being arranged to form M subsequent multicarrier symbols, the payload part comprising K2 frequency sub-channels, the filterbank-based multicarrier transmitter comprising a processor being configured to assign subsequent pilot values of a pilot sequence to every Pth frequency sub-channel of the K1 frequency sub-channels to obtain a pilot symbol of the multicarrier signal, and to assign subsequent payload values of a payload sequence to subsequent frequency sub-channels of the K2 frequency sub-channels to obtain a payload symbol of the multicarrier signal, and wherein the processor is configured to assign subsequent groups of subsequent pilot values to every Qth symbol of the M multicarrier symbols.

Abstract: The present invention is directed to a transmitter and receivers for filterbank multicarrier (FBMC) communication. The transmitter comprises a processor adapted to calculate two auxiliary pilot symbols, and a precoder adapted to insert the two calculated auxiliary pilot symbols into a symbol structure of symbols, the symbols adjacently surrounding a main pilot symbol, wherein the precoder is adapted to insert the two auxiliary pilot symbols at two symbol positions of the symbol structure, which are symmetric to the main pilot symbol P in a time domain and/or in a frequency domain.

Abstract: The disclosure discloses a method and a system for implementing projection.

Abstract: A filterbank-based multicarrier transmitter for transmitting a multicarrier signal is disclosed, the multicarrier signal comprising a synchronization part and a payload part, the synchronization part comprising K1 frequency sub-channels being arranged to form M subsequent multicarrier symbols, the payload part comprising K2 frequency sub-channels, the filterbank-based multicarrier transmitter comprising a processor being configured to assign subsequent pilot values of a pilot sequence to every Pth frequency sub-channel of the K1 frequency sub-channels to obtain a pilot symbol of the multicarrier signal, and to assign subsequent payload values of a payload sequence to subsequent frequency sub-channels of the K2 frequency sub-channels to obtain a payload symbol of the multicarrier signal, and wherein the processor is configured to assign subsequent groups of subsequent pilot values to every Qth symbol of the M multicarrier symbols.

Abstract: The disclosure discloses a method and a system for implementing projection.

Abstract: A system and method for monitoring respiration of a user, comprising: a respiration sensing module including a sensor configured to detect a set of respiration signals of the user based upon movement resulting from the user's respiration; a supplementary sensing module comprising an accelerometer and configured to detect a set of supplemental signals from the user; an electronics subsystem comprising a power module configured to power the system and a signal processing module configured to condition the set of respiration signals and the set of supplemental signals; a housing configured to facilitate coupling of the respiration sensing module and the supplementary sensing module to the user; and a data link coupled to the electronics subsystem through the housing and configured to transmit data generated from the set of respiration signals and the set of supplemental signals, thereby facilitating monitoring of the user's respiration.

Abstract: The present disclosure provides compositions for inhibiting proteases, methods for synthesizing the compositions, and methods of using the disclosed protease inhibitors. Aspects of the disclosure include a peptidyl propenoyl hydrazide compositions that inhibit proteases, for example cysteine proteases, either in vivo or in vitro.

Abstract: The present invention provides compositions for inhibiting proteases, methods for synthesizing the compositions, and methods of using the disclosed protease inhibitors. Aspects of the invention include aza-peptide epoxide compositions that inhibit proteases, for example cysteine proteases, either in vivo or in vitro. The disclosed compounds, pharmaceutically acceptable salts, pharmaceutically acceptable derivatives, prodrugs, or combinations thereof can be used to treat disease or pathological conditions related to the activity of proteases associated with a specific disease or condition. Such treatable conditions include viral infections, stroke, neurodegenerative disease, and inflammatory disease, among others.

Abstract: The present invention provides compositions for inhibiting proteases, methods for synthesizing the compositions, and methods of using the disclosed protease inhibitors. Aspects of the invention include aza-peptide epoxide compositions that inhibit proteases, for example cysteine proteases, either in vivo or in vitro. The disclosed compounds, pharmaceutically acceptable salts, pharmaceutically acceptable derivatives, prodrugs, or combinations thereof can be used to treat disease or pathological conditions related to the activity of proteases associated with a specific disease or condition. Such treatable conditions include viral infections, stroke, neurodegenerative disease, and inflammatory disease, among others.